Skip to main content
PHYSIOMICS PLC logo

PHYSIOMICS PLC — Investor Relations & Filings

Ticker · PYC ISIN · GB00BDR6W943 LEI · 213800A71DSZ6ABMTQ91 IL Professional, scientific and technical activities
Open in API
Filings indexed 332 across all filing types
Latest filing 2016-09-21 Capital/Financing Update
Country GB United Kingdom
Listing IL PYC

About PHYSIOMICS PLC

https://www.physiomics.co.uk/

Physiomics PLC is a data-driven consultancy that provides Model-Informed Drug Development (MIDD) services to pharmaceutical and biotechnology companies. The company specializes in accelerating and de-risking the development of new drugs by integrating expertise in Modelling & Simulation, Biostatistics, and Data Science. By applying quantitative pharmacology and pharmacokinetic/pharmacodynamic (PK/PD) modelling, Physiomics supports clients in making smarter, data-driven decisions throughout the drug development pipeline, from preclinical discovery to clinical trials. The company has a notable focus on oncology, leveraging advanced computational biology platforms to optimize treatment strategies and predict patient outcomes.

Recent filings

Filing Released Lang Actions
Placing and Update on Acquisition
Capital/Financing Update Classification · 98% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details a 'Placing' (fundraising) of new ordinary shares, the resulting increase in issued share capital, and a decision to abandon a previously announced acquisition. This is a corporate action announcement related to financing and capital structure. The most fitting category is 'Capital/Financing Update' (CAP). Although it is an RNS filing, CAP is more specific to the content than the general 'RNS' fallback.
2016-09-21 English
Result of GM
AGM Information Classification · 99% confidence The document is very short (754 characters) and explicitly states it is an 'RNS Number' announcement from the London Stock Exchange. The content announces the 'Result of General Meeting' where all resolutions were passed. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which details the outcome of shareholder votes at a general meeting. Although it is an RNS announcement, DVA is a more specific category for voting results than the general RNS fallback.
2016-09-07 English
Notice of General Meeting
Regulatory Filings Classification · 98% confidence The document is an RNS announcement (indicated by 'RNS Number : 7193H' and 'This information is provided by RNS'). The content explicitly states that the company has 'published and posted to shareholders a circular in relation to a forthcoming General Meeting' and mentions shareholder resolutions. This document is an announcement about the upcoming General Meeting and the associated circular, not the AGM presentation itself (AGM-R) or the voting results (DVA). Since it is an announcement regarding a formal corporate action/document release via the RNS system, and it is short and serves to inform the market of the publication of a 'Shareholder Circular and Notice of General Meeting', it fits best as a Report Publication Announcement (RPA) or, given the RNS header, potentially RNS. However, the core action is announcing the publication of a circular for a meeting. The presence of 'Notice of General Meeting' suggests it is related to the meeting process. Given the options, 'RPA' (Report Publication Announcement) is suitable as it announces the publication of the circular. Alternatively, since it is a formal notice related to a meeting and shareholder action, 'AGM-R' might be considered if the circular is the primary AGM material, but RPA is more accurate for the announcement itself. Since the document announces the publication of a 'Circular' which contains the 'Notice of General Meeting', and it is very short, RPA is the most precise fit based on Rule 2 (announcement of publication). If the circular itself were provided, it might be AGM-R or PSI. I will classify it as RPA because it is an announcement of publication.
2016-08-22 English
Signing of Share Purchase Agreement with BioMoti
M&A Activity Classification · 99% confidence The document begins with 'RNS Number : 4844H' and is dated August 18, 2016. It announces a significant corporate action: the signing of a Share Purchase Agreement for the acquisition of BioMoti Limited, contingent on a fundraising placing. This type of announcement, detailing a major transaction (M&A activity) and associated financing, is typically disseminated via regulatory news services. Since the content is a detailed announcement of a transaction rather than a general regulatory filing fallback (RNS) or a specific financial report (like 10-K or IR), the most fitting category is M&A Activity (TAR). However, the document explicitly ends with 'This information is provided by RNS' and uses the RNS numbering system, which often suggests a general regulatory announcement. Given the core subject is a takeover/acquisition proposal, TAR (M&A Activity) is highly relevant. If TAR was not available, RNS would be the fallback. Since TAR is available and the content is a detailed announcement of a takeover/acquisition, TAR is the primary classification. The document length (6610 chars) is substantial enough to be the primary announcement, not just a brief RPA.
2016-08-18 English
Advisor Changes
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated August 16, 2016. The content announces a change in the company's advisors ('Advisor Changes'), specifically the appointment of Hybridan LLP as a joint broker. This type of announcement, which conveys material, non-public information to the market via an official channel (RNS), fits best under the general 'Regulatory Filings' category, as it does not specifically match definitions for financial reports (10-K, IR, ER), management changes (MANG), or director dealings (DIRS). Since it is a standard regulatory news service announcement, RNS is the most appropriate code.
2016-08-16 English
Extensions for Virtual Tumour Project
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and is dated May 16, 2016. The content announces an 'Update: 6th and 7th extension projects to advance oncology candidate with global pharma company' and discusses a fee-for-service project extension. This is a general announcement of corporate activity released via the Regulatory News Service (RNS). Since it is not a specific financial report (like 10-K, IR, ER) or a specific corporate action announcement (like DIV, CAP, DIRS), and it is clearly an official regulatory news release, the most appropriate classification is the general regulatory filing category, RNS.
2016-05-16 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.